Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

Clinical trial NCT01307631 · COMPLETED

Trial details

NCT number: NCT01307631
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma

Start date: 2011-03-01
Primary completion: 2015-09-18
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.